CD79a (C-Term) Rabbit Monoclonal

Confirm delete?

CD79a (C-Term) Rabbit Monoclonal Antibody

Zoom

Cat No: 32243

CD79a is a member of the heterodimeric signal transduction component of the B cell receptor (BCR) complex that is encoded by CD79A/MB-1 in humans.{54536} It is composed of a disulfide-linked extracellular domain, a transmembrane region, and a cytoplas...

This product can only be bought through Cayman Chemical. Please contact us.

Product Overview
Data
Downloads
About Cayman

Territorial Availability: Available through Bertin Technologies only in France

Correlated keywords:

CD 79a 79b RM 297 MB1 extra intra cellular Ig alpha

Product Overview:
CD79a is a member of the heterodimeric signal transduction component of the B cell receptor (BCR) complex that is encoded by CD79A/MB-1 in humans.{54536} It is composed of a disulfide-linked extracellular domain, a transmembrane region, and a cytoplasmic tail containing an immunoreceptor tyrosine-based activation motif that facilitates intracellular signaling.{54536,54537} CD79a is expressed exclusively in B cells and B cell progenitors, and is commonly used as a B cell marker. It is co-expressed at the cell surface with CD79b and immunoglobulins of all isotypes as the mature BCR complex.{54536} Mutations in CD79A/MB-1 have been found in patients with autosomal recessive agammaglobulinemia.{54538} Cayman's CD79a (C-Term) Rabbit Monoclonal Antibody can be used for immunohistochemistry (IHC) and Western blot (WB) applications.

Size	100 µl
Shipping	dry ice
Host	Rabbit
Antigen	Peptide from the C-terminal region of human CD79a
Clone	RM297
Isotype	IgG
Application(s)	IHC, WB
Formulation	100 µl of protein A-affinity purified monoclonal antibody
Custom Code	3822.19
UNSPSC code	12352203

Technical File

MSDS

Click here to ask for your quote and get 15% off Cayman's products.

Cayman Chemical's mission is to help make research possible by supplying scientists worldwide with the basic research tools necessary for advancing human and animal health. Our utmost commitment to healthcare researchers is to offer the highest quality products with an affordable pricing policy.

Our scientists are experts in the synthesis, purification, and characterization of biochemicals ranging from small drug-like heterocycles to complex biolipids, fatty acids, and many others. We are also highly skilled in all aspects of assay and antibody development, protein expression, crystallization, and structure determination.

Over the past thirty years, Cayman developed a deep knowledge base in lipid biochemistry, including research involving the arachidonic acid cascade, inositol phosphates, and cannabinoids. This knowledge enabled the production of reagents of exceptional quality for cancer, oxidative injury, epigenetics, neuroscience, inflammation, metabolism, and many additional lines of research.

Our organic and analytical chemists specialize in the rapid development of manufacturing processes and analytical methods to carry out clinical and commercial GMP-API production. Pre-clinical drug discovery efforts are currently underway in the areas of bone restoration and repair, muscular dystrophy, oncology, and inflammation. A separate group of Ph.D.-level scientists are dedicated to offering Hit-to-Lead Discovery and Profiling Services for epigenetic targets. Our knowledgeable chemists can be contracted to perform complete sample analysis for analytes measured by the majority of our assays. We also offer a wide range of analytical services using LC-MS/MS, HPLC, GC, and many other techniques.

Accreditations
ISO/IEC 17025:2005
ISO Guide 34:2009

Cayman is a leader in the field of emerging drugs of abuse, providing high-purity Schedule I-V Controlled Substances to federally-licensed laboratories and qualified academic research institutions for forensic analyses. We are certified by ACLASS Accreditation Services with dual accreditation to ISO/IEC 17025:2005 and ISO Guide 34:2009.